Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,468,736
+$129,413 QoQ
Shares Held
15,102
-0.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#790
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOWER BRIDGE ADVISORS holds $63,752,721 across 8 Drug Manufacturers - General names. AMGN ranks #5 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
89,561 | $22,745,806 | |
| 2 | NVS |
Novartis AG
|
69,416 | $10,878,875 | |
| 3 | ABBV |
AbbVie Inc.
|
38,900 | $9,788,796 | |
| 4 | LLY |
ELI LILLY & Co
|
6,601 | $7,917,438 | |
| 5 | AMGN |
Amgen Inc
This page
|
15,102 | $5,468,736 | |
| 6 | MRK |
Merck & Co., Inc.
|
34,852 | $4,478,482 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
26,527 | $1,528,485 | |
| 8 | PFE |
Pfizer Inc
|
39,290 | $946,103 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,468,736 | 15,102 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,339,323 | 15,175 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,765,306 | 14,559 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,171,480 | 14,782 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,127,840 | 14,784 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $4,333,348 | 13,909 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $3,513,166 | 13,479 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $4,252,849 | 13,199 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $4,060,600 | 12,996 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $4,367,155 | 15,360 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $4,359,758 | 15,137 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,089,989 | 15,218 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $3,346,063 | 15,071 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $4,233,284 | 17,511 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $4,297,053 | 16,361 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $3,721,579 | 16,511 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,057,757 | 16,678 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $4,059,674 | 16,788 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $3,743,050 | 16,638 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $3,766,669 | 17,713 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $4,279,762 | 17,558 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,954,834 | 15,895 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,585,602 | 15,595 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,760,312 | 6,926 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,633,566 | 6,926 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $1,414,852 | 6,979 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||